Page last updated: 2024-11-11

10-hydroxystearic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

10-hydroxystearic acid: structure given in first source; see also record for 10(9)-hydroxystearic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

10-hydroxyoctadecanoic acid : A hydroxy fatty acid that is octadecanoic acid carrying a hydroxy group at position 10. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9561835
CHEBI ID143095
SCHEMBL ID240199
MeSH IDM0191683

Synonyms (36)

Synonym
unii-384m5b7ifl
nsc 79060
ai3-26309
384m5b7ifl ,
nsc-79060
octadecanoic acid, 10-hydroxy-
b 190696
10-hydroxystearic acid
usda 10-hydroxystearic acid
nsc79060
638-26-6
rosilic acid
AKOS000277642
CHEBI:143095
10-hydroxy-octadecanoic acid
10-hydroxy stearic acid
10-hydroxyoctadecanoic acid
dl-10-hydroxy stearic acid
LMFA02000128
SCHEMBL240199
PAZZVPKITDJCPV-UHFFFAOYSA-N
10-hydroxystearic acid, (+/-)-
stearic acid, .iota.-hydroxy-
10-hydroxystearic acid [inci]
dl-10-hydroxystearic acid
FT-0699563
AKOS028108373
AS-58969
xi-10-hydroxyoctadecanoic acid
mfcd08693364
Q27256742
SY243389
A901228
DTXSID901314578
CS-0186310
10-hydroxyoctadecanoicacid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dosing continuous cultures of mixed ruminal microorganisms with 1-(13C)-oleic acid increased the 13C enrichment of both HSA and KSA at 24 h postdosing, and showed that the majority (96 and 85%, respectively) of the HSA and KSA present in the 24-h samples originated from oleic acid."( The production of 10-hydroxystearic and 10-ketostearic acids is an alternative route of oleic acid transformation by the ruminal microbiota in cattle.
Abughazaleh, AA; Freeman, S; Jenkins, TC; Thies, EJ, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
hydroxy fatty acidAny fatty acid carrying one or more hydroxy substituents.
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Octadecanoid formation from linoleic acid028

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's9 (30.00)18.2507
2000's6 (20.00)29.6817
2010's10 (33.33)24.3611
2020's3 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.79 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index36.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.23%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (93.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]